Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-107 in acne vulgaris
NCT01194375Phase 2Completed
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Sep 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of minocycline in acne vulgaris, sponsored by Dow Pharmaceutical Sciences. Started Sep 2010; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01194375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194375.